Several studies have shown that the composition of Tregs and Th17 cells may be altered in the tumor microenvironment, and that these two CD4 + T cell subsets play active roles in promoting lung cancer progression and metastasis [20]. The gene discussed is CD4; the disease is lung carcinoma.